売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/2 |
365,879 |
59.5% |
| 2023/2 |
463,475 |
58.7% |
| 2022/1 |
535,214 |
59.4% |
| 2021/1 |
561,034 |
56.8% |
| 2020/1 |
552,765 |
54.3% |
| 2019/2 |
518,709 |
52.6% |
| 2018/2 |
467,904 |
51.5% |
| 2017/2 |
429,502 |
50.5% |
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/2 |
-111,966 |
-30.6% |
| 2023/2 |
-148,029 |
-31.9% |
| 2022/1 |
-52,374 |
-9.8% |
| 2021/1 |
-32,835 |
-5.9% |
| 2020/1 |
-52,174 |
-9.4% |
| 2019/2 |
-48,732 |
-9.4% |
| 2018/2 |
-83,045 |
-17.7% |
| 2017/2 |
-65,953 |
-15.4% |
|
（単位：%）
|
2017/2
|
2018/2
|
2019/2
|
2020/1
|
2021/1
|
2022/1
|
2023/2
|
2024/2
|
|
売上高
|
429,502
|
467,904
|
518,709
|
552,765
|
561,034
|
535,214
|
463,475
|
365,879
|
|
売上成長率（％）
|
-
|
|
|
6.6
|
1.5
|
-4.6
|
-13.4
|
-21.1
|
|
売上原価
|
212,599
|
226,718
|
246,117
|
252,796
|
242,167
|
217,126
|
191,642
|
148,120
|
|
売上総利益
|
216,903
|
241,186
|
272,592
|
299,969
|
318,867
|
318,088
|
271,833
|
217,759
|
|
売上総利益率（％）
|
|
|
|
54.3
|
56.8
|
59.4
|
58.7
|
59.5
|
|
研究開発費
|
71,030
|
80,164
|
87,608
|
94,964
|
105,008
|
122,494
|
141,837
|
110,996
|
|
営業費用
|
282,856
|
324,231
|
321,324
|
352,143
|
351,702
|
370,462
|
419,862
|
329,725
|
|
営業利益
|
-65,953
|
-83,045
|
-48,732
|
-52,174
|
-32,835
|
-52,374
|
-148,029
|
-111,966
|
|
営業利益率 (%)
|
|
|
|
-9.4
|
-5.9
|
-9.8
|
-31.9
|
-30.6
|
|
経常（税引前）利益
|
-63,477
|
-85,780
|
-45,954
|
-51,324
|
-31,801
|
-55,906
|
-146,781
|
-114,520
|
|
経常（税引前）利益率（％）
|
-14.8
|
-18.3
|
-8.9
|
-9.3
|
-5.7
|
-10.4
|
-31.7
|
-31.3
|
|
法人税等合計
|
-25,264
|
-57,703
|
-6,853
|
-19,658
|
-9,899
|
-16,115
|
-32,282
|
-28,478
|
|
実効税率（％）
|
|
|
|
38.3
|
31.1
|
28.8
|
22.0
|
24.9
|
|
純利益
|
-38,213
|
-28,077
|
-39,101
|
-31,666
|
-21,902
|
-39,791
|
-114,499
|
-86,042
|
|
純利益率（％）
|
|
|
|
-5.7
|
-3.9
|
-7.4
|
-24.7
|
-23.5
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-1
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-1
|
|
EBITDA
|
|
|
|
-9,242
|
8,779
|
-11,854
|
-111,361
|
-80,073
|
|
EBITDAマージン（％）
|
|
|
|
-1.7
|
1.6
|
-2.2
|
-24.0
|
-21.9
|